Construction and Synergistic Effect of Recombinant Yeast Co-expressing Pig IL-2/4/6 on Immunity of Piglets to PRRS Vaccination

Abstract

In order to develop cost-effective immunomodulator, the recombinant Pichia pastoris were firstly constructed to co-express porcine IL-2/4/6 genes, and then fermented to feed 45-days Tibetan piglets at different doses to evaluate its effects on immunity of piglets to PRRS vaccination, which simultaneously received intramuscular injection of inactivated PRRS vaccine. The results were found that the leukocytes, IgG and specific antibody to PRRSV, Th and Tc cells increased significantly in the blood of treated piglets in comparison with those of the control (P < 0.05); the mRNA expression of TLRs (TLR-2, 3, 4, 7, 9), IFN-γ, IL-2, IL-4, IL-6, IL-7, IL-12 and IL-15 genes were elevated significantly in the immune cells from the blood of treated piglets (P < 0.05). Moreover, the growth of the treated piglets also markedly improved whose average net weight gain was significantly higher than the control on 58 days post inoculation (P < 0.05). These results suggest that the recombinant yeast can effectively enhance the systematic innate and adaptive immunity of piglets as well as promote the growth of piglet, which could be further developed as cost-effective promising immunomodulator to improve the control of pig PRRS disease.